Biocardia to participate in upcoming investor conferences

San carlos, calif., aug. 13, 2021 (globe newswire) -- biocardia®, inc. (nasdaq: bcda), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announced today that the company's management team will participate in the following upcoming investor conferences:
BCDA Ratings Summary
BCDA Quant Ranking